Published in Kidney Int on January 01, 2000
Modification of Diet in Renal Transplantation (MDRT) (MDRT) | NCT03612778
Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol (2010) 1.68
Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol (2008) 1.62
Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. Am J Transplant (2011) 1.56
Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. Clin J Am Soc Nephrol (2012) 1.46
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol (2012) 1.44
Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg (2016) 1.39
Belatacept in renal transplantation-quo vadis? Transl Androl Urol (2016) 1.38
Kidney transplantation in the elderly. Semin Nephrol (2009) 1.27
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ (2005) 1.26
Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol (2008) 1.23
Disparities in kidney transplant outcomes: a review. Semin Nephrol (2010) 1.21
Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol (2009) 1.11
Prospective study of urinary tract infection surveillance after kidney transplantation. BMC Infect Dis (2010) 1.02
Management and prevention of post-transplant malignancies in kidney transplant recipients. Clin Kidney J (2015) 0.97
Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol (2009) 0.93
Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care (2011) 0.89
Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited. Clin J Am Soc Nephrol (2008) 0.88
Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol (2011) 0.86
Beta and angiotensin blockades are associated with improved 10-year survival in renal transplant recipients. J Am Heart Assoc (2013) 0.86
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol (2011) 0.85
Echocardiography-based score to predict outcome after renal transplantation. Heart (2006) 0.85
Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipient. J Nephropathol (2015) 0.84
Differential outcomes of expanded-criteria donor renal allografts according to recipient age. Clin J Am Soc Nephrol (2012) 0.83
Over ten-year kidney graft survival determinants. Int J Nephrol (2012) 0.83
Bone disease after renal transplantation. Nat Rev Nephrol (2009) 0.81
Percutaneous fixation of anterior column acetabular fracture in a renal transplant recipient. Case Rep Orthop (2013) 0.80
Intraoperative hyperglycemia augments ischemia reperfusion injury in renal transplantation: a prospective study. J Transplant (2011) 0.80
Primary care of the renal transplant patient. J Gen Intern Med (2010) 0.80
Chronic kidney disease stage progression in liver transplant recipients. Clin J Am Soc Nephrol (2011) 0.80
Antihypertensive agents and renal transplantation. Hippokratia (2007) 0.80
Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79
A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation. Trials (2010) 0.79
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients. Transplant Res (2013) 0.78
Causes of death in renal transplant recipients with functioning allograft. Indian J Nephrol (2012) 0.78
Association studies of calcium-sensing receptor (CaSR) polymorphisms with serum concentrations of glucose and phosphate, and vascular calcification in renal transplant recipients. PLoS One (2015) 0.78
Revascularization options in patients with chronic kidney disease. Tex Heart Inst J (2010) 0.78
Metabolic syndrome and coronary artery calcification in renal transplant recipients. Transplantation (2008) 0.78
Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up. PLoS One (2015) 0.78
Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation. Transplant Direct (2016) 0.77
A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol (2016) 0.77
The effect of intensive nutrition interventions on weight gain after kidney transplantation: protocol of a randomised controlled trial. BMC Nephrol (2014) 0.77
Close to transplant renal artery stenosis and percutaneous transluminal treatment. J Transplant (2011) 0.77
Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia. Singapore Med J (2014) 0.77
Dynamics of circulating microparticles in chronic kidney disease and transplantation: Is it really reliable marker? World J Transplant (2015) 0.77
Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study. NDT Plus (2010) 0.76
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients. Transplantation (2014) 0.76
Interferon-γ-Mediated Allograft Rejection Exacerbates Cardiovascular Disease of Hyperlipidemic Murine Transplant Recipients. Circ Res (2015) 0.76
Reuse of a previously transplanted kidney: does success come with a price? Clin Kidney J (2012) 0.76
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics J (2015) 0.76
Risk Factors of Graft Survival After Diagnosis of Post-kidney Transplant Malignancy: Using Cox Proportional Hazard Model. Iran Red Crescent Med J (2015) 0.75
Predictors and prognostic implications of major adverse cardiovascular events after renal transplant: 10 years outcomes in 321 patients. Int J Angiol (2014) 0.75
Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single center. Diabetol Metab Syndr (2015) 0.75
Racial and Ethnic Disparities in Graft and Recipient Survival in Elderly Kidney Transplant Recipients. J Am Geriatr Soc (2015) 0.75
Superior outcomes of kidney transplantation compared with dialysis: An optimal matched analysis of a national population-based cohort study between 2005 and 2008 in Korea. Medicine (Baltimore) (2016) 0.75
Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts. PLoS One (2016) 0.75
Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study. Health Qual Life Outcomes (2012) 0.75
Cardiac evaluation prior to kidney transplantation. Semin Dial (2010) 0.75
Prospective controlled protocol for three months steroid withdrawal with tacrolimus, basiliximab, and mycophenolate mofetil in renal transplant recipients. J Korean Med Sci (2012) 0.75
Should post kidney transplantation hyperlipidemia considered a risk factor for graft function? Int J Organ Transplant Med (2010) 0.75
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. BMC Med Genomics (2014) 0.75
Death with functioning kidney transplant: an obituarial analysis. Int Urol Nephrol (2010) 0.75
Hypertension in dialysis and kidney transplant patients. Can J Cardiol (2009) 0.75
Diagnosis and treatment of coronary artery disease in hemodialysis patients evaluated for transplant. Transplant Res (2012) 0.75
Cardiovascular disease: Risk factors and applicability of a risk model in a Greek cohort of renal transplant recipients. World J Transplant (2017) 0.75
Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. Sci Rep (2015) 0.75
3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol (2017) 0.75
Lipid lowering in renal disease. Aust Prescr (2017) 0.75
Stress SPECT Myocardial Perfusion Imaging in End-Stage Renal Disease. Curr Cardiovasc Imaging Rep (2017) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA (1993) 3.10
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Median sensory distal amplitude and latency: comparisons between nonexposed managerial/professional employees and industrial workers. Am J Ind Med (1993) 2.87
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther (1997) 2.17
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care (1999) 1.82
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve (1992) 1.80
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant (1997) 1.73
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Use of community versus individual socioeconomic data in predicting variation in hospital use. Health Serv Res (1998) 1.64
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
The effect of bystander CPR on survival of out-of-hospital cardiac arrest victims. Am Heart J (1985) 1.61
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58
Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant (2010) 1.55
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol (2000) 1.55
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors. Am J Transplant (2012) 1.46
Patterns of low incidence of treated end-stage renal disease among the elderly. Am J Kidney Dis (1992) 1.45
Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders. Q J Med (1989) 1.43
Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis (2000) 1.43
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41
Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol (1994) 1.40
Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol (2001) 1.40
Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int (1992) 1.38
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35